Adjuvant Therapy for Breast Cancer: Recommendations for Management Based on Consensus Review and Recent Clinical Trials
Author:
Affiliation:
1. Division of General Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA
2. Multidisciplinary Breast Clinic, Mayo Clinic, Jacksonville, Florida, USA
3. Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.7-3-246
Reference15 articles.
1. Polychemotherapy for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
2. Tamoxifen for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
3. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000;Eifel;J Natl Cancer Inst,2001
4. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer;Goldhirsch;J Natl Cancer Inst,1998
5. Adjuvant anti-HER monoclonal antibody therapy—ready for breast cancer?;Perez;The Breast,2001
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-utility analysis of different venous access devices in breast cancer patients: a decision-based analysis model;BMC Health Services Research;2023-05-16
2. Comparison of comfort and complications of Implantable Venous Access Port (IVAP) with ultrasound guided Internal Jugular Vein (IJV) and Axillary Vein/Subclavian Vein (AxV/SCV) puncture in breast cancer patients: a randomized controlled study;BMC Cancer;2022-03-05
3. Comparison of comfort and complications in breast cancer patients of implantable venous access port (IVAP) with ultrasound guided internal jugular vein (IJV) and axillary vein/subclavian vein (AxV/SCV) puncture: a randomized controlled study protocol;Annals of Palliative Medicine;2020-11
4. COL‑3 enhances the anti‑proliferative and pro‑apoptotic effects of paclitaxel in breast cancer cells;Oncology Reports;2018-10-22
5. Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I;Asia-Pacific Journal of Clinical Oncology;2016-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3